Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression
Completed
- Conditions
- Treatment Resistant Depression
- Interventions
- Drug: Monoamine Oxidase Inhibitor (MAOI)
- First Posted Date
- 2017-04-12
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Kathryn O'Connor
- Target Recruit Count
- 11
- Registration Number
- NCT03109717
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
News
No news found